A detailed history of Dafna Capital Management LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 207,427 shares of STOK stock, worth $2.2 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
207,427
Previous 207,427 -0.0%
Holding current value
$2.2 Million
Previous $2.8 Million 9.03%
% of portfolio
0.66%
Previous 0.72%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.03 - $17.52 $688,569 - $1.09 Million
62,427 Added 43.05%
207,427 $2.8 Million
Q1 2024

May 15, 2024

BUY
$4.12 - $14.17 $597,400 - $2.05 Million
145,000 New
145,000 $1.96 Million

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $418M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.